Primary |
Pain |
22.7% |
Rheumatoid Arthritis |
11.9% |
Arthritis |
9.7% |
Back Pain |
9.7% |
Osteoarthritis |
6.7% |
Product Used For Unknown Indication |
6.3% |
Arthralgia |
5.2% |
Hypertension |
4.5% |
Thrombosis Prophylaxis |
4.5% |
Cancer Pain |
2.2% |
Musculoskeletal Pain |
2.2% |
Prostate Cancer |
2.2% |
Drug Use For Unknown Indication |
1.9% |
Spinal Osteoarthritis |
1.9% |
Cachexia |
1.5% |
Insomnia |
1.5% |
Myocardial Infarction |
1.5% |
Neck Pain |
1.5% |
Pain In Extremity |
1.5% |
Inflammation |
1.1% |
|
Gastrointestinal Haemorrhage |
12.4% |
Renal Failure Acute |
12.4% |
Rectal Haemorrhage |
9.7% |
Vomiting |
8.0% |
Gastric Haemorrhage |
7.1% |
Completed Suicide |
5.3% |
Urticaria |
5.3% |
Colitis Microscopic |
4.4% |
Death |
3.5% |
Duodenal Ulcer Perforation |
3.5% |
Pruritus |
3.5% |
Toxic Epidermal Necrolysis |
3.5% |
Diarrhoea |
2.7% |
Haematemesis |
2.7% |
Hyperkalaemia |
2.7% |
Oedema Peripheral |
2.7% |
Pain |
2.7% |
Pneumothorax |
2.7% |
Renal Failure |
2.7% |
Respiratory Arrest |
2.7% |
|
Secondary |
Headache |
15.0% |
Rheumatoid Arthritis |
13.4% |
Product Used For Unknown Indication |
12.4% |
Drug Use For Unknown Indication |
9.0% |
Bone Disorder |
7.5% |
Respiratory Disorder |
7.5% |
Pain |
6.6% |
Prophylaxis |
5.5% |
Multiple Myeloma |
3.8% |
Hypertension |
3.3% |
Back Pain |
2.7% |
Metastatic Renal Cell Carcinoma |
2.7% |
Thrombosis Prophylaxis |
2.6% |
Arthritis |
1.2% |
Cachexia |
1.2% |
Cancer Pain |
1.2% |
Constipation |
1.2% |
Insomnia |
1.2% |
Neck Pain |
1.1% |
Osteoporosis |
1.1% |
|
Toxicity To Various Agents |
11.2% |
Completed Suicide |
10.3% |
Death |
7.5% |
Drug Hypersensitivity |
7.5% |
Stomatitis |
5.6% |
Pain In Extremity |
4.7% |
Pyrexia |
4.7% |
Respiratory Arrest |
4.7% |
White Blood Cell Count Increased |
4.7% |
Anaemia |
3.7% |
Atrial Fibrillation |
3.7% |
Drug Toxicity |
3.7% |
Interstitial Lung Disease |
3.7% |
Pleural Effusion |
3.7% |
Renal Failure |
3.7% |
Sepsis |
3.7% |
Somnolence |
3.7% |
White Blood Cell Count Decreased |
3.7% |
Aplastic Anaemia |
2.8% |
Cardio-respiratory Arrest |
2.8% |
|
Concomitant |
Rheumatoid Arthritis |
26.9% |
Product Used For Unknown Indication |
18.3% |
Drug Use For Unknown Indication |
12.7% |
Prophylaxis |
6.8% |
Pain |
5.8% |
Hypertension |
4.7% |
Depression |
3.0% |
Osteoporosis |
2.7% |
Insomnia |
2.4% |
Anxiety |
1.9% |
Multiple Myeloma |
1.9% |
Metastatic Renal Cell Carcinoma |
1.7% |
Arthritis |
1.5% |
Breast Cancer Metastatic |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Renal Cell Carcinoma |
1.4% |
Breast Cancer |
1.4% |
Gastritis |
1.4% |
Asthma |
1.3% |
Psoriatic Arthropathy |
1.2% |
|
Vomiting |
12.8% |
Pneumonia |
7.2% |
Rash |
5.9% |
Pain |
5.8% |
Weight Decreased |
5.8% |
Weight Increased |
5.8% |
Pyrexia |
5.6% |
Nausea |
5.2% |
White Blood Cell Count Increased |
5.1% |
Pulmonary Embolism |
4.7% |
Type 2 Diabetes Mellitus |
4.7% |
Urinary Tract Infection |
4.5% |
Drug Ineffective |
3.8% |
Myocardial Infarction |
3.5% |
Rheumatoid Arthritis |
3.5% |
White Blood Cell Count Decreased |
3.5% |
Pneumocystis Jiroveci Pneumonia |
3.3% |
Headache |
3.1% |
Hepatic Function Abnormal |
3.1% |
Wound Treatment |
3.0% |
|